• 제목/요약/키워드: Pulmonary infection

검색결과 666건 처리시간 0.037초

Disseminated Mycobacterium intracellulare Infection in an Immunocompetent Host

  • Kim, Won-Young;Jang, Sun-Joo;Ok, Tae-Jin;Kim, Gwang-Un;Park, Han-Seung;Leem, Jae-Chan;Kang, Bo-Hyoung;Park, Se-Jeong;Oh, Dong-Kyu;Kang, Byung-Ju;Lee, Bo-Young;Ji, Won-Jun;Shim, Tae-Sun
    • Tuberculosis and Respiratory Diseases
    • /
    • 제72권5호
    • /
    • pp.452-456
    • /
    • 2012
  • Disseminated Mycobacterium avium complex (MAC) infection can occur in immunocompromised patients, and rarely in immunocompetent subjects. Due to the extensive distribution of the disease, clinical presentation of disseminated MAC may mimic malignancies, and thorough examinations are required in order to make accurate diagnosis. We report a case of disseminated Mycobacterium intracellulare disease in an immunocompetent patient, which involved the lung, lymph nodes, spleen, and multiple bones. F-18 fluorodeoxyglucose positron-emission tomography imaging showed multiple hypermetabolic lesions, which are suggestive of typical hematogenous metastasis. However, there was no evidence of malignancy in serial biopsies, and M. intracellulare was repeatedly cultured from respiratory specimens and bones. Herein, we should know that disseminated infection can occur in the immunocompetent subjects, and it can mimic malignancies.

면역저하가 없는 환자에서 Alcaligenes xylosoxidans 에 의한 호흡기계 감염 2예 (Two Cases of Pulmonary Infection due to A. xylosoxidans Infection in an Immunocompentent Patient)

  • 이주현;남동혁;김도현;김선혜;김하나;한창훈;이선민;김정주
    • Tuberculosis and Respiratory Diseases
    • /
    • 제64권1호
    • /
    • pp.33-38
    • /
    • 2008
  • A. xylosoxidans는 면역저하 상태에서 기회감염을 일으키며 호흡기 감염은 매우 드문 균으로 알려져 있다. 저자들은 최근 면역저하가 없는 환자에서 발생한 A. xylosoxidans에 의한 호흡기 감염증을 2예 경험하였기에 문헌 고찰과 함께 보고한다. 본 증례를 통해 정상면역을 가진 환자에서 A. xylosoxidans가 호흡기 감염의 원인일 수 있으며, 이와 같은 경우 세균학적 검사결과에 따른 적절한 치료가 필수적이라는 것을 경험하였다.

Enterovirus 71 infection and neurological complications

  • Lee, Kyung Yeon
    • Clinical and Experimental Pediatrics
    • /
    • 제59권10호
    • /
    • pp.395-401
    • /
    • 2016
  • Since the outbreak of the enterovirus 71 (EV71) infection in Malaysia in 1997, large epidemics of EV71 have occurred in the Asia-Pacific region. Many children and infants have died from serious neurological complications during these epidemics, and EV71 infection has become a serious public health problem in these areas. EV71 infection causes hand, foot and mouth disease (HFMD) in children, and usually resolves spontaneously. However, EV71 occasionally involves the central nervous system (CNS), and induces diverse neurological complications such as brainstem encephalitis, aseptic meningitis, and acute flaccid paralysis. Among those complications, brainstem encephalitis is the most critical neurological manifestation because it can cause neurogenic pulmonary hemorrhage/edema leading to death. The characteristic clinical symptoms such as myoclonus and ataxia, cerebrospinal fluid (CSF) pleocytosis, and brainstem lesions on magnetic resonance imaging, in conjunction with the skin rash of HFMD and the isolation of EV71 from a stool, throat-swab, or CSF sample are typical findings indicating CNS involvement of EV71 infection. Treatment with intravenous immunoglobulin and milrinone are recommended in cases with severe neurological complications from EV71 infection, such as brainstem encephalitis. Despite the recent discovery of receptors for EV71 in human cells, such as the scavenger receptor B2 and P-selection glycoprotein ligand 1, it is not known why EV71 infection predominantly involves the brainstem. Recently, 3 companies in China have completed phase III clinical trials of EV71 vaccines. However, the promotion and approval of these vaccines in various countries are problems yet to be resolved.

Pulmonary Strongyloidiasis Masquerading as Exacerbation of Chronic Obstructive Pulmonary Disease

  • Pradhan, Gourahari;Behera, Priyadarshini;Panigrahi, Manoj Kumar;Bhuniya, Sourin;Mohapatra, Prasanta Raghab;Turuk, Jyotirmayee;Mohanty, Srujana
    • Tuberculosis and Respiratory Diseases
    • /
    • 제79권4호
    • /
    • pp.307-311
    • /
    • 2016
  • Pulmonary strongyloidiasis is an uncommon presentation of Strongyloides infection, usually seen in immunocompromised hosts. The manifestations are similar to that of acute exacerbation of chronic obstructive pulmonary disease (COPD). Therefore, the diagnosis of pulmonary strongyloidiasis could be challenging in a COPD patient, unless a high index of suspicion is maintained. Here, we present a case of Strongyloides hyperinfection in a COPD patient mimicking acute exacerbation, who was on chronic steroid therapy.

폐종괴와 기관지 탄분섬유화로 발현한 Mycobacterium kansasii 감염 1 예 (Mycobacterium Kansasii Disease Presenting As a Lung Mass and Bronchial Anthracofibrosis)

  • 나승원;이광하;정주영;강호석;박이내;최혜숙;정훈;전규락;심태선
    • Tuberculosis and Respiratory Diseases
    • /
    • 제60권4호
    • /
    • pp.464-468
    • /
    • 2006
  • 폐종괴로 발현하는 M. kansasii 감염은 흔하지 않으며 기관지 탄분섬유화증을 동반한 M. kansasii 폐감염에 대한 보고는 아직 없었다. 기저질환 없이 면역력이 정상인 비흡연자에서 우하엽의 폐종괴로 발현하고 기관지 탄분섬유화증을 동반한 M. kansasii 폐감염에 대하여 표준 치료로 호전되고 있는 증례를 경험하였기에 보고하는 바이다.

혈액암 환자에서 합병된 침습성 폐아스페르길루스증의 수술적 치료 (Pulmonary Resection for Invasive Pulmonary Aspergillosis in Hematological Malignancy Patients)

  • 사영조;김용한;남상용;심성보;이선희;박재길
    • Journal of Chest Surgery
    • /
    • 제40권9호
    • /
    • pp.617-623
    • /
    • 2007
  • 배경: 침습성 폐아스페르길루스증은 면역체계가 낮은 환자들에게 흔한 진균감염으로, 특히 백혈병으로 항암제 치료를 받고 있는 환자들에서는 항진균제 치료에 반응이 적은 것으로 알려져 있다. 저자들은 백혈병의 치료 중 합병된 폐아스페르길루스증에 대하여 모두 폐절제술을 시행하였으며, 그의 효과 등을 알아보고자 하였다. 대상 및 방법: 1998년 2월부터 2007년 4월까지 혈액암 질환의 진단과 함께 침습성 폐아스페르길루스증 진단을 받은 환자 14명을 대상으로 후향적인 검토를 하였다. 환자의 의무기록을 통해 혈액암(기저질환)의 종류와 그에 따른 치료, 침습성 폐아스페르길루스증의 진단방법, 수술 전 혈액학적 상태와 처치, 수술방법, 수술 후 합병증과 사망여부, 수술 후 폐아스페르길루스증의 재발현율 및 골수이식 여부 등을 조사하였다. 결과: 침습성 폐아스페르길루스증이 합병된 혈액암 환자 14명에서 모두 폐엽절제술이 시행되었다. 수술 후 1명의 환자에서 기관지흉막루가 발생되었으나, 기타 창상감염, 출혈 등의 위중한 합병증이나 수술 후 사망한 환자는 없었으며, 모두 백혈병치료를 지속할 수 있었다. 결론: 침습성 폐아스페르길루스증은 혈액암에 대한 치료 도중 종종 발생되는 위중한 질환이나, 폐엽절제술은 안전하며 효과적으로 혈액암의 치료를 유지시켜 줄 수 있는 치료법으로 생각한다.

흉부 외상 후 발생한 가성 폐낭종: 치험1례 (Traumatic Pulmonary Pseudocyst - A case report -)

  • 전예지;한동기;곽영태
    • Journal of Chest Surgery
    • /
    • 제24권2호
    • /
    • pp.222-226
    • /
    • 1991
  • Authors recently experienced a case of traumatic pulmonary pseudocyst in 4 year-old girl. Traumatic pulmonary cyst is a rare complication of blunt thoracic trauma, simulating surgical conditions such as lung abscess, localized empyema, or congenital bronchogenic cyst. Unless infection is supervened, surgery is not indicated because of its spontaneous regression. In this article, authors present the case and review the traumatic pulmonary pseudocyst with related articles.

  • PDF

10년 동안 성장한 거대 폐국균종 치험 1례 (Growing Pulmonary Aspergilloma for 10 Years - One Case Report -)

  • 심성보
    • Journal of Chest Surgery
    • /
    • 제24권8호
    • /
    • pp.814-818
    • /
    • 1991
  • Infection with the ubiquitous fungus Aspergillus is uncommon. This organism has a low pathogenicity for man. In most patients, pulmonary Aspergilloma is the most common form of disease, and Aspergillus fumigatus is the common species. The natural history of the pulmonary aspergilloma is variable. This report reviews the feature of growing pulmonary aspergilloma for 10 years[from diameter 3cm to diameter 9cm]. This 44-year-old male patient suffered from recurrent hemoptysis for 10 years. This patient was taken removal of aspergilloma and cavernoplasty of left upper lobe. Post-operation course was uneventful.

  • PDF

Characteristics and Outcomes of Patients with Pulmonary Acute Respiratory Distress Syndrome Infected with Influenza versus Other Respiratory Viruses

  • Yoo, Jung-Wan;Ju, Sunmi;Lee, Seung Jun;Cho, Min-Chul;Cho, Yu Ji;Jeong, Yi Yeong;Lee, Jong Deog;Kim, Ho Choel
    • Tuberculosis and Respiratory Diseases
    • /
    • 제82권4호
    • /
    • pp.328-334
    • /
    • 2019
  • Background: Although the frequency of respiratory viral infection in patients with pulmonary acute respiratory distress syndrome (ARDS) is not uncommon, clinical significance of the condition remains to be further elucidated. The purpose of this study was to compare characteristics and outcomes of patients with pulmonary ARDS infected with influenza and other respiratory viruses. Methods: Clinical data of patients with pulmonary ARDS infected with respiratory viruses January 2014-June 2018 were reviewed. Respiratory viral infection was identified by multiplex reverse transcription-polymerase chain reaction (RT-PCR). Results: Among 126 patients who underwent multiplex RT-PCR, respiratory viral infection was identified in 46% (58/126): 28 patients with influenza and 30 patients with other respiratory viruses. There was no significant difference in baseline and clinical characteristics between patients with influenza and those with other respiratory viruses. The use of extracorporeal membrane oxygenation (ECMO) was more frequent in patients with influenza than in those with other respiratory viruses (32.1% vs 3.3%, p=0.006). Co-bacterial pathogens were more frequently isolated from respiratory samples of patients with pulmonary ARDS infected with influenza virus than those with other respiratory viruses. (53.6% vs 26.7%, p=0.036). There were no significant differences regarding clinical outcomes. In multivariate analysis, acute physiology and chronic health evaluation II was associated with 30-mortality (odds ratio, 1.158; 95% confidence interval, 1.022-1.312; p=0.022). Conclusion: Respiratory viral infection was not uncommon in patients with pulmonary ARDS. Influenza virus was most commonly identified and was associated with more co-bacterial infection and ECMO therapy.

Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis

  • Kim, Ju;Yang, Ye Lin;Jeong, Yongsu;Jang, Yong-Suk
    • Journal of Microbiology and Biotechnology
    • /
    • 제30권3호
    • /
    • pp.427-438
    • /
    • 2020
  • Middle East respiratory syndrome coronavirus (MERS-CoV) infects the lower respiratory airway of humans, leading to severe acute respiratory failure. Unlike human dipeptidyl peptidase 4 (hDPP4), a receptor for MERS-CoV, mouse DPP4 (mDPP4) failed to support MERS-CoV infection. Consequently, diverse transgenic mouse models expressing hDPP4 have been developed using diverse methods, although some models show no mortality and/or only transient and mild-to-moderate clinical signs following MERS-CoV infection. Additionally, overexpressed hDPP4 is associated with neurological complications and breeding difficulties in some transgenic mice, resulting in impeding further studies. Here, we generated stable hDPP4-transgenic mice that were sufficiently susceptible to MERS-CoV infection. The transgenic mice showed weight loss, decreased pulmonary function, and increased mortality with minimal perturbation of overexpressed hDPP4 after MERS-CoV infection. In addition, we observed histopathological signs indicative of progressive pulmonary fibrosis, including thickened alveolar septa, infiltration of inflammatory monocytes, and macrophage polarization as well as elevated expression of profibrotic molecules and acute inflammatory response in the lung of MERS-CoV-infected hDPP4-transgenic mice. Collectively, we suggest that this hDPP4-transgenic mouse is useful in understanding the pathogenesis of MERS-CoV infection and for antiviral research and vaccine development against the virus.